542 related articles for article (PubMed ID: 19061610)
1. Inflammatory morphea in the context of Raynaud phenomenon.
Abbasi N; Firoz B; Bossenbroek NM; Meehan SA; Kamino H; Franks AG
Dermatol Online J; 2008 Oct; 14(10):11. PubMed ID: 19061610
[TBL] [Abstract][Full Text] [Related]
2. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma?
Sachsenberg-Studer EM; Prins C; Saurat JH; Salomon D
J Am Acad Dermatol; 2000 Oct; 43(4):631-4. PubMed ID: 11004618
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of CREST syndrome and primary biliary cirrhosis. Serological studies of two cases.
Hirakata M; Akizuki M; Miyachi K; Matsushima H; Okano T; Homma M
J Rheumatol; 1988 Jul; 15(7):1166-70. PubMed ID: 3172118
[TBL] [Abstract][Full Text] [Related]
4. [Generalized morphea-like progressive systemic sclerosis with anticentromere antibodies and eosinophilic cellulitis].
Sasaki T; Nakajima H; Kameda Y
Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):469-76. PubMed ID: 2614990
[TBL] [Abstract][Full Text] [Related]
5. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
6. [Anticentromere antibodies and lung disease without skin involvement].
Fernández-Fernández FJ; Sesma P; Facio A; Guerra JL; González-Moraleja J
An Med Interna; 1997 Apr; 14(4):196-8. PubMed ID: 9181818
[TBL] [Abstract][Full Text] [Related]
7. [Raynaud's phenomenon and anti-centromeric antibodies].
Marquet R; Villar MM; Ordi J; de la Figuera M; Vilardell M
Med Clin (Barc); 1984 Jun; 83(3):129-30. PubMed ID: 6482556
[No Abstract] [Full Text] [Related]
8. [How to recognize scleroderma].
Francès C; Ayoub N; Barete S
Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
[TBL] [Abstract][Full Text] [Related]
9. [Differential diagnosis of Osler's telangiectasia and the CREST syndrome: significance of centromere antibodies].
Stolz W; Ring J; Meurer M
Hautarzt; 1988 Jun; 39(6):371-4. PubMed ID: 3403273
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of scleroderma and pseudoscleroderma.
Fabri M; Hunzelmann N
J Dtsch Dermatol Ges; 2007 Nov; 5(11):977-84. PubMed ID: 17976138
[TBL] [Abstract][Full Text] [Related]
11. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.
Fett N; Werth VP
J Am Acad Dermatol; 2011 Feb; 64(2):217-28; quiz 229-30. PubMed ID: 21238823
[TBL] [Abstract][Full Text] [Related]
12. [Morphea resembling pseudoxanthoma elasticum in progressive scleroderma].
Steigleder GK; Müller HD; Noack M
Z Hautkr; 1978 Dec; 53(23):829-33. PubMed ID: 726540
[TBL] [Abstract][Full Text] [Related]
13. [Neurological and psychological syndromes of scleroderma (author's transl)].
Gottwald W; Benos J
Fortschr Neurol Psychiatr Grenzgeb; 1974 May; 42(5):225-63. PubMed ID: 4603711
[No Abstract] [Full Text] [Related]
14. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
Doyle JA; Connolly SM; Winkelmann RK
Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
[TBL] [Abstract][Full Text] [Related]
15. Guttate morphea in a scleroderma spectrum disorder patient with anticentromere antibody.
Yamanaka M; Ishikawa O
Eur J Dermatol; 2009; 19(6):630-1. PubMed ID: 19596641
[No Abstract] [Full Text] [Related]
16. Systemic sclerosis sine scleroderma: is it always the same disease? Report of three patients and discussion.
Slobodin G; Rosner I; Rozenbaum M; Naschitz JE; Zuckerman E; Yeshurun D
Rheumatol Int; 2002 Aug; 22(4):170-2. PubMed ID: 12172958
[TBL] [Abstract][Full Text] [Related]
17. Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis.
Shoji I; Takagi T; Kasukawa R
Intern Med; 1992 Dec; 31(12):1348-55. PubMed ID: 1284406
[TBL] [Abstract][Full Text] [Related]
18. [The clinical picture of morphea].
Wojas-Pelc A; Wielowieyska-Szybińska D
Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
[TBL] [Abstract][Full Text] [Related]
19. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
20. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).
Follansbee WP; Miller TR; Curtiss EI; Orie JE; Bernstein RL; Kiernan JM; Medsger TA
J Rheumatol; 1990 May; 17(5):656-62. PubMed ID: 2359076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
